CRISPR based biosensing: An ultrasensitive theranostic tool for the detection of early Breast Cancer biomarkers – A mini review
According to The International Agency for Research on Cancer (IARC) survey, the most commonly diagnosed breast cancer (BC) encumbrance will rise to ˃3 million with ˃1 million bereavements per year by 2040. This creates a high demand for effective early diagnosis of BC to reduce psychological and eco...
Main Authors: | Sundaram Sornambikai, Karutha Pandian Divya, Subramanian Vasanth, Chinnuswamy Viswanathan, Nagamony Ponpandian |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Biosensors and Bioelectronics: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S259013702300064X |
Similar Items
-
An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology
by: Mina Roueinfar, et al.
Published: (2022-02-01) -
Editorial: Disease biomarker analysis based on optical biosensing
by: Tianshu Chen, et al.
Published: (2023-04-01) -
CRISPR-based biosensing is prospective for rapid and sensitive diagnosis of pediatric tuberculosis
by: Chunyang Lyu, et al.
Published: (2020-12-01) -
CRISPR/Cas13-Based Approaches for Ultrasensitive and Specific Detection of microRNAs
by: Javier T. Granados-Riveron, et al.
Published: (2021-07-01) -
CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges
by: Jian Zhou, et al.
Published: (2024-02-01)